September 02, 2018
1 min read
Save

OSN’s week in review: Top stories

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Here are some of the week’s top ophthalmology stories:

 

Research explores work, wealth and worth for women in ophthalmology

Age disparity in ophthalmology is a complex topic, with growing interest in research on career advancement, recognition and income of women, according to Ashvini Reddy, MD, associate professor at Dean McGee Eye Institute. Read more.

 

Femtosecond arcuate keratotomy advantageous in astigmatic correction

Compared to manual limbal relaxing incisions performed in conventional phacoemulsification cataract surgery, nonpenetrating femtosecond laser arcuate keratotomy performed during femtosecond laser-assisted cataract surgery can achieve an astigmatic correction of greater magnitude, according to a study. Read more.

 

Alcon calls for surgeons to stop implanting CyPass micro-stent

Citing “uncompromising commitment to patient safety,” Alcon has announced an immediate, voluntary withdrawal of all versions of the CyPass micro-stent from the global market and advises surgeons to immediately cease further implantation of the device. Read more.

 

Tetra submits orphan drug applications for cannabinoid-based treatments

Tetra Bio-Pharma has submitted multiple orphan drug applications to the FDA for cannabinoid treatment of rare cancers and ocular diseases, the company announced. Read more.

 

Adverum IND application activated for AMD treatment

Adverum Biotechnologies announced its investigational new drug application is now active for its planned phase 1 study of ADVM-022, a novel gene therapy candidate for the treatment of wet age-related macular degeneration. Read more.